Logo image of HY

HYSTER-YALE INC (HY) Stock Fundamental Analysis

USA - NYSE:HY - US4491721050 - Common Stock

36.63 USD
-1.34 (-3.53%)
Last: 9/19/2025, 4:15:00 PM
36.63 USD
0 (0%)
After Hours: 9/19/2025, 4:15:00 PM
Fundamental Rating

3

Overall HY gets a fundamental rating of 3 out of 10. We evaluated HY against 128 industry peers in the Machinery industry. HY may be in some trouble as it scores bad on both profitability and health. HY has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

HY had positive earnings in the past year.
HY had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HY reported negative net income in multiple years.
HY had a positive operating cash flow in 4 of the past 5 years.
HY Yearly Net Income VS EBIT VS OCF VS FCFHY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

HY has a Return On Assets of 1.07%. This is in the lower half of the industry: HY underperforms 65.63% of its industry peers.
HY has a worse Return On Equity (4.08%) than 62.50% of its industry peers.
HY has a Return On Invested Capital (7.08%) which is in line with its industry peers.
Industry RankSector Rank
ROA 1.07%
ROE 4.08%
ROIC 7.08%
ROA(3y)3.14%
ROA(5y)0.52%
ROE(3y)8.66%
ROE(5y)-3.29%
ROIC(3y)N/A
ROIC(5y)N/A
HY Yearly ROA, ROE, ROICHY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin of HY (0.56%) is worse than 67.19% of its industry peers.
HY's Profit Margin has improved in the last couple of years.
HY has a Operating Margin of 2.95%. This is in the lower half of the industry: HY underperforms 69.53% of its industry peers.
HY's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 18.89%, HY is doing worse than 74.22% of the companies in the same industry.
In the last couple of years the Gross Margin of HY has grown nicely.
Industry RankSector Rank
OM 2.95%
PM (TTM) 0.56%
GM 18.89%
OM growth 3YN/A
OM growth 5Y29.18%
PM growth 3YN/A
PM growth 5Y24.88%
GM growth 3Y20.72%
GM growth 5Y4.68%
HY Yearly Profit, Operating, Gross MarginsHY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

3

2. Health

2.1 Basic Checks

HY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HY has more shares outstanding than it did 1 year ago.
HY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HY has been reduced compared to a year ago.
HY Yearly Shares OutstandingHY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
HY Yearly Total Debt VS Total AssetsHY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

HY has an Altman-Z score of 2.83. This is not the best score and indicates that HY is in the grey zone with still only limited risk for bankruptcy at the moment.
HY has a Altman-Z score (2.83) which is comparable to the rest of the industry.
HY has a debt to FCF ratio of 5.21. This is a neutral value as HY would need 5.21 years to pay back of all of its debts.
HY's Debt to FCF ratio of 5.21 is in line compared to the rest of the industry. HY outperforms 47.66% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that HY is somewhat dependend on debt financing.
HY has a worse Debt to Equity ratio (0.62) than 61.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.21
Altman-Z 2.83
ROIC/WACC0.79
WACC8.91%
HY Yearly LT Debt VS Equity VS FCFHY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

HY has a Current Ratio of 1.40. This is a normal value and indicates that HY is financially healthy and should not expect problems in meeting its short term obligations.
HY has a worse Current ratio (1.40) than 78.91% of its industry peers.
HY has a Quick Ratio of 1.40. This is a bad value and indicates that HY is not financially healthy enough and could expect problems in meeting its short term obligations.
HY's Quick ratio of 0.65 is on the low side compared to the rest of the industry. HY is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.65
HY Yearly Current Assets VS Current LiabilitesHY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2

3. Growth

3.1 Past

HY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.10%.
HY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 35.91% yearly.
The Revenue has decreased by -7.11% in the past year.
Measured over the past years, HY shows a small growth in Revenue. The Revenue has been growing by 5.53% on average per year.
EPS 1Y (TTM)-72.1%
EPS 3YN/A
EPS 5Y35.91%
EPS Q2Q%-103.91%
Revenue 1Y (TTM)-7.11%
Revenue growth 3Y11.89%
Revenue growth 5Y5.53%
Sales Q2Q%-18.11%

3.2 Future

The Earnings Per Share is expected to decrease by -11.16% on average over the next years. This is quite bad
HY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.12% yearly.
EPS Next Y-78.71%
EPS Next 2Y-36.99%
EPS Next 3Y-19.99%
EPS Next 5Y-11.16%
Revenue Next Year-11.66%
Revenue Next 2Y-5.9%
Revenue Next 3Y-2.87%
Revenue Next 5Y-1.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HY Yearly Revenue VS EstimatesHY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
HY Yearly EPS VS EstimatesHY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.13, HY is valued correctly.
Based on the Price/Earnings ratio, HY is valued cheaply inside the industry as 89.84% of the companies are valued more expensively.
HY is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.31 indicates a reasonable valuation of HY.
Based on the Price/Forward Earnings ratio, HY is valued cheaper than 92.19% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. HY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.13
Fwd PE 10.31
HY Price Earnings VS Forward Price EarningsHY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HY is valued cheaper than 96.88% of the companies in the same industry.
HY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HY is cheaper than 96.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.15
EV/EBITDA 6.05
HY Per share dataHY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

A cheap valuation may be justified as HY's earnings are expected to decrease with -19.99% in the coming years.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y-36.99%
EPS Next 3Y-19.99%

6

5. Dividend

5.1 Amount

HY has a Yearly Dividend Yield of 3.90%.
HY's Dividend Yield is rather good when compared to the industry average which is at 1.74. HY pays more dividend than 96.09% of the companies in the same industry.
HY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.9%

5.2 History

The dividend of HY has a limited annual growth rate of 1.92%.
HY has been paying a dividend for at least 10 years, so it has a reliable track record.
HY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.92%
Div Incr Years11
Div Non Decr Years11
HY Yearly Dividends per shareHY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

111.71% of the earnings are spent on dividend by HY. This is not a sustainable payout ratio.
HY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP111.71%
EPS Next 2Y-36.99%
EPS Next 3Y-19.99%
HY Yearly Income VS Free CF VS DividendHY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
HY Dividend Payout.HY Dividend Payout, showing the Payout Ratio.HY Dividend Payout.PayoutRetained Earnings

HYSTER-YALE INC

NYSE:HY (9/19/2025, 4:15:00 PM)

After market: 36.63 0 (0%)

36.63

-1.34 (-3.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners61.59%
Inst Owner Change-0.1%
Ins Owners17.34%
Ins Owner Change0.85%
Market Cap649.08M
Analysts82
Price Target51 (39.23%)
Short Float %4.1%
Short Ratio6.77
Dividend
Industry RankSector Rank
Dividend Yield 3.9%
Yearly Dividend1.39
Dividend Growth(5Y)1.92%
DP111.71%
Div Incr Years11
Div Non Decr Years11
Ex-Date08-29 2025-08-29 (0.36)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-60.81%
Min EPS beat(2)-122.84%
Max EPS beat(2)1.22%
EPS beat(4)2
Avg EPS beat(4)-42.6%
Min EPS beat(4)-122.84%
Max EPS beat(4)3.42%
EPS beat(8)5
Avg EPS beat(8)10.66%
EPS beat(12)8
Avg EPS beat(12)74.11%
EPS beat(16)10
Avg EPS beat(16)7.04%
Revenue beat(2)0
Avg Revenue beat(2)-3.81%
Min Revenue beat(2)-6.74%
Max Revenue beat(2)-0.87%
Revenue beat(4)1
Avg Revenue beat(4)-3.21%
Min Revenue beat(4)-6.74%
Max Revenue beat(4)1.38%
Revenue beat(8)3
Avg Revenue beat(8)-0.74%
Revenue beat(12)6
Avg Revenue beat(12)0.98%
Revenue beat(16)9
Avg Revenue beat(16)1.24%
PT rev (1m)-10.71%
PT rev (3m)-10.71%
EPS NQ rev (1m)-227.27%
EPS NQ rev (3m)-114%
EPS NY rev (1m)-17.59%
EPS NY rev (3m)-17.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.76%
Revenue NY rev (1m)1.97%
Revenue NY rev (3m)1.97%
Valuation
Industry RankSector Rank
PE 13.13
Fwd PE 10.31
P/S 0.16
P/FCF 7.15
P/OCF 4.53
P/B 1.19
P/tB 1.43
EV/EBITDA 6.05
EPS(TTM)2.79
EY7.62%
EPS(NY)3.55
Fwd EY9.7%
FCF(TTM)5.12
FCFY13.99%
OCF(TTM)8.09
OCFY22.08%
SpS222.95
BVpS30.74
TBVpS25.7
PEG (NY)N/A
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 1.07%
ROE 4.08%
ROCE 11.3%
ROIC 7.08%
ROICexc 7.52%
ROICexgc 8.22%
OM 2.95%
PM (TTM) 0.56%
GM 18.89%
FCFM 2.3%
ROA(3y)3.14%
ROA(5y)0.52%
ROE(3y)8.66%
ROE(5y)-3.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y35.18%
ROICexc growth 3YN/A
ROICexc growth 5Y37.6%
OM growth 3YN/A
OM growth 5Y29.18%
PM growth 3YN/A
PM growth 5Y24.88%
GM growth 3Y20.72%
GM growth 5Y4.68%
F-Score5
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.21
Debt/EBITDA 2.08
Cap/Depr 113.39%
Cap/Sales 1.33%
Interest Coverage 250
Cash Conversion 87.91%
Profit Quality 409.01%
Current Ratio 1.4
Quick Ratio 0.65
Altman-Z 2.83
F-Score5
WACC8.91%
ROIC/WACC0.79
Cap/Depr(3y)81.76%
Cap/Depr(5y)92.33%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.1%
EPS 3YN/A
EPS 5Y35.91%
EPS Q2Q%-103.91%
EPS Next Y-78.71%
EPS Next 2Y-36.99%
EPS Next 3Y-19.99%
EPS Next 5Y-11.16%
Revenue 1Y (TTM)-7.11%
Revenue growth 3Y11.89%
Revenue growth 5Y5.53%
Sales Q2Q%-18.11%
Revenue Next Year-11.66%
Revenue Next 2Y-5.9%
Revenue Next 3Y-2.87%
Revenue Next 5Y-1.12%
EBIT growth 1Y-59.3%
EBIT growth 3YN/A
EBIT growth 5Y36.32%
EBIT Next Year-43.59%
EBIT Next 3Y-12.4%
EBIT Next 5Y-3.99%
FCF growth 1Y48.61%
FCF growth 3YN/A
FCF growth 5Y35.41%
OCF growth 1Y68.19%
OCF growth 3YN/A
OCF growth 5Y17.35%